Neurocia SAS
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Neurocia SAS is a medtech company that develops non-invasive radiofrequency neuromodulation devices to treat neurodegenerative disorders such as Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurocia SAS Comparables
Compare Neurocia SAS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| REGEnLIFE | 83% | |
| NeuroEM Therapeutics | 82% | |
| Bottneuro AG | 81% | |
Neurocia SAS Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 56% MoM.
- Mar 2, 2026
Monthly visitors increased 72% MoM.
Neurocia SAS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurocia SAS's valuation, stock price, and market status.